Discontinue use if markedly elevated creatinine kinase (>5 x ULN) occurs or ILD is suspected. Not to be used in patients w/ acute, serious condition suggestive of myopathy or predisposing to development of renal failure secondary to rhabdomyolysis eg, sepsis, hypotension, major surgery, trauma, severe metabolic, endocrine & electrolyte disorders or uncontrolled seizures. Predisposing factors for myopathy/rhabdomyolysis eg, hypothyroidism, history of hereditary muscular disorders or toxicity; situations where increased plasma levels occur. Immune-mediated necrotising myopathy; DM; proteinuria. Assess renal function during routine follow-up. Perform LFT prior to & 3 mth after initiation of treatment. Asian patients. Avoid excessive alcohol consumption. Galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Not recommended in concomitant use w/ fibric derivatives eg, gemfibrozil, ciclosporin, nicotinic acid, azole antifungals, PIs, macrolides. Concomitant use w/ fibrates, niacin. History of liver disease. Severe renal impairment. Women of childbearing potential should use effective contraception. Pregnancy & lactation. Childn <10 yr. Elderly >70 yr.